- Report
- February 2024
- 70 Pages
Asia Pacific
From €4316EUR$4,750USD£3,710GBP
- Report
- February 2024
- 80 Pages
Latin America
From €4316EUR$4,750USD£3,710GBP
- Report
- August 2023
- 112 Pages
North America
From €4316EUR$4,750USD£3,710GBP
- Report
- August 2023
- 90 Pages
North America
From €4316EUR$4,750USD£3,710GBP
- Report
- August 2023
- 70 Pages
Europe
From €4316EUR$4,750USD£3,710GBP
- Report
- December 2023
- 142 Pages
Brazil
From €2272EUR$2,500USD£1,953GBP
- Report
- July 2024
- 139 Pages
Global
From €2272EUR$2,500USD£1,953GBP
- Report
- May 2024
- 128 Pages
Global
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- May 2024
- 129 Pages
Global
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- May 2024
- 140 Pages
Global
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- May 2024
- 130 Pages
Global
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- June 2026
- 138 Pages
United Kingdom
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- April 2026
- 142 Pages
Japan
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- April 2026
- 148 Pages
Germany
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- April 2026
- 143 Pages
Russia
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- April 2026
- 143 Pages
China
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- April 2026
- 150 Pages
Saudi Arabia
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- April 2026
- 141 Pages
Turkey
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- April 2026
- 136 Pages
Italy
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP
- Report
- April 2026
- 141 Pages
Spain
From €2725EUR$2,999USD£2,343GBP
€3634EUR$3,999USD£3,124GBP

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more